Vesicare

Go or no go? Covid-19 upstages US regulatory decisions
EP Vantage
Tue, 03/24/20 - 10:30 am
FDA
regulatory
Bristol-Myers Squibb
ozanimod
Esteve
E-58425
Fabre-Kramer
AstraZeneca
Imfinzi
Astellas
Vesicare
AbbVie
Neurocrine
Orlissa
Sanofi
MenQuadfi
opicapone
Acceleron
Reblozyl
Astellas Pharma, Teva Reach Settlement Over Incontinence Medicine Vesicare
Bloomberg
Mon, 06/28/10 - 09:58 am
Astellas
Teva Pharmaceuticals
settlements
Vesicare
urinary incontinence
Those FDA Warning Letters To Glaxo & Novartis
Pharmalot
Mon, 04/19/10 - 11:05 am
FDA
warnings
GSK
Novartis
Arzerra
Vesicare
Astellas
Voltaren